332 related articles for article (PubMed ID: 22405700)
41. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis.
Lehman EM; Wilson ML
Int J Cancer; 2009 Feb; 124(3):690-7. PubMed ID: 18973270
[TBL] [Abstract][Full Text] [Related]
42. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan.
Hatch MC; Chen CJ; Levin B; Ji BT; Yang GY; Hsu SW; Wang LW; Hsieh LL; Santella RM
Int J Cancer; 1993 Jul; 54(6):931-4. PubMed ID: 8392983
[TBL] [Abstract][Full Text] [Related]
43. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
44. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
[TBL] [Abstract][Full Text] [Related]
45. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.
Sun Z; Chen T; Thorgeirsson SS; Zhan Q; Chen J; Park JH; Lu P; Hsia CC; Wang N; Xu L; Lu L; Huang F; Zhu Y; Lu J; Ni Z; Zhang Q; Wu Y; Liu G; Wu Z; Qu C; Gail MH
Carcinogenesis; 2013 Aug; 34(8):1800-5. PubMed ID: 23322152
[TBL] [Abstract][Full Text] [Related]
46. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology and natural history of hepatocellular carcinoma.
McGlynn KA; London WT
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
[TBL] [Abstract][Full Text] [Related]
48. Aflatoxin and liver cancer in Sudan.
Omer RE; Bakker MI; van't Veer P; Hoogenboom RL; Polman TH; Alink GM; Idris MO; Kadaru AM; Kok FJ
Nutr Cancer; 1998; 32(3):174-80. PubMed ID: 10050268
[TBL] [Abstract][Full Text] [Related]
49. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
[TBL] [Abstract][Full Text] [Related]
50. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
Ayoola EA
IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
[TBL] [Abstract][Full Text] [Related]
51. Aflatoxin and liver cancer.
Jackson PE; Groopman JD
Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
[TBL] [Abstract][Full Text] [Related]
52. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
53. Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide.
Palliyaguru DL; Wu F
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2013; 30(3):534-40. PubMed ID: 23281740
[TBL] [Abstract][Full Text] [Related]
54. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
55. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
56. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
57. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
58. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
59. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
60. Primary prevention of hepatocellular carcinoma.
Yu SZ
J Gastroenterol Hepatol; 1995; 10(6):674-82. PubMed ID: 8580413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
